IFLR1000

The Carlyle Group Rs37 billion acquisition of 20% stake in Piramal Pharma

27/6/2020
Public acquisition
Select tab

Re 37 billion

$ 496.265 million

Announced

27/6/2020

Overview:

  • Multinational private equity firm The Carlyle Group has acquired a 20% stake in pharmaceuticals company Piramal Pharma for Rs37 billion.

Shah Shameer Ahmed - Researcher 

Jurisdiction:

India

Deal type:

Public acquisition

Practice area:

M&A

Industry sector:

Pharmaceuticals and life sciences

Firms:
AZB & Partners

Party: The Carlyle Group (Acquirer)

Cyril Amarchand Mangaldas

Party: Piramal Group (Seller)

Lawyers: Cyril Shroff, Radhika Gaggar

Related deals